Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 30.84%
March 31, 2026 -2.46%
December 31, 2025 74.77%
September 30, 2025 71.34%
June 30, 2025 66.06%
March 31, 2025 65.39%
December 31, 2024 72.25%
September 30, 2024 72.39%
June 30, 2024 74.20%
March 31, 2024 70.58%
December 31, 2023 68.02%
September 30, 2023 71.67%
June 30, 2023 74.71%
March 31, 2023 71.14%
December 31, 2022 74.34%
September 30, 2022 73.74%
Date Value
June 30, 2022 76.79%
March 31, 2022 71.90%
December 31, 2021 72.16%
September 30, 2021 75.80%
June 30, 2021 72.66%
March 31, 2021 71.84%
December 31, 2020 74.84%
September 30, 2020 75.53%
June 30, 2020 69.82%
March 31, 2020 66.77%
December 31, 2019 69.53%
September 30, 2019 70.23%
June 30, 2019 70.47%
March 31, 2019 70.27%
December 31, 2018 72.47%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
cbdMD, Inc. 50.03%
Guardian Pharmacy Services, Inc. 22.75%
ACADIA Pharmaceuticals, Inc. 90.81%
Agenus, Inc. 98.50%
Alnylam Pharmaceuticals, Inc. 76.88%

Gross Profit Margin (Quarterly) Related Metrics